STAPHYLOCOCCUS AUREUS UC-18: AGENT OF NOSOCOMIAL INFECTIONS

Area of Science:

• Microbiology
• Infectious Diseases
• Bacteriology

Background:

• Hospital-acquired infections (HAIs) pose a significant challenge in healthcare settings.
• Staphylococcus aureus is a common pathogen responsible for numerous HAIs.
• The emergence of antibiotic-resistant strains necessitates continuous surveillance and characterization.

Purpose of the Study:

• To identify and characterize a new strain of Staphylococcus aureus implicated in severe hospital-acquired infections.
• To investigate the susceptibility of this novel strain to bacteriophage lysis.
• To assess the prevalence and clinical significance of this strain in the hospital environment.

Main Methods:

• Isolation and identification of Staphylococcus aureus strains from clinical samples.
• Bacteriophage susceptibility testing using a newly isolated bacteriophage, UC-18.
• Antimicrobial susceptibility testing to determine resistance patterns to penicillin, streptomycin, and tetracycline.
• Epidemiological surveillance to assess the prevalence of the identified strain in the hospital.

Main Results:

• A novel strain of Staphylococcus aureus, designated S. aureus UC-18, was identified.
• This strain demonstrated specific lysis upon exposure to bacteriophage UC-18.
• S. aureus UC-18 exhibited resistance to penicillin, streptomycin, and tetracycline.
• The strain was found to be widespread in the hospital environment, contributing to endemic staphylococcal disease.

Conclusions:

• The newly identified S. aureus UC-18 strain is a significant cause of hospital-acquired infections.
• Its resistance to multiple antibiotics and prevalence in hospitals highlight its clinical importance.
• Bacteriophage UC-18 shows potential for the characterization and possibly therapeutic targeting of this strain.